^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
QLS32015
i
Other names: QLS32015
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Qilu Pharma
Drug class:
CD3 agonist, GPRC5D inhibitor
Related drugs:
over1year
A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma (clinicaltrials.gov)
P1, N=100, Recruiting, Qilu Pharmaceutical Co., Ltd.
New P1 trial
|
QLS32015
Share via
